Fundraising FoxMicromgx
Evanston, US · Founded 2022 · Delaware corporation · 3 known investors
Find your way into Micromgx
Sign up to see every warm intro you have to Micromgx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Micromgx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MicroMGx runs a high-throughput natural product discovery process that combines metabolomics and genomics (metabologenomics) to find bioactive compounds produced by microbes, supplying patented natural products to life science R&D organizations. Its portfolio includes a novel-mode-of-action herbicide and an anti-parasitic anthelmintic candidate for use in crops, livestock, pets, and humans.
Founders & leadership
Micromgx was founded in 2022 by Regan Thomson, William Metcalf, Jack Kloeber, and Neil L. Kelleher.
Board
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$500KofferedMay 2026 · AgricultureRule 506(b)
- Regan ThomsonDirector, Promoter
- Jennifer KelleherExecutive Officer
- William MetcalfDirector, Promoter
- Neil KelleherDirector, Promoter
- Jack KloeberExecutive Officer, Promoter
- Anthony GoeringDirector
- Offering amount
- $500K
- Minimum investment
- $10K
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Micromgx.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Micromgx do?
- MicroMGx runs a high-throughput natural product discovery process that combines metabolomics and genomics (metabologenomics) to find bioactive compounds produced by microbes, supplying patented natural products to life science R&D organizations. Its portfolio includes a novel-mode-of-action herbicide and an anti-parasitic anthelmintic candidate for use in crops, livestock, pets, and humans.
- Who founded Micromgx?
- Micromgx was founded by Regan Thomson, William Metcalf, Jack Kloeber, Neil L. Kelleher in 2022.
- Who are Micromgx's investors?
- Micromgx's investors include Ag Ventures Alliance, AgLaunch Accelerator, The Innovation Space.
- Where is Micromgx headquartered?
- Micromgx is headquartered in Evanston, US.